ASAHI INTECC Launches Veloute™ and Tellus™ Embolization Microcatheters in the U.S.

Next-generation deliverability and control for peripheral embolization — available September 8, 2025

IRVINE, Calif., Sept. 8, 2025 /PRNewswire/ -- ASAHI INTECC today announced the U.S. commercial launch of Veloute™ and Tellus™. These medical devices are indicated for angiography and infusion of therapeutic and diagnostic agents — including embolization — in the peripheral vasculature.

Designed for control in tortuous anatomy

Engineered for precise navigation and reliable delivery, Veloute™ and Tellus™ feature:

• Proprietary braid-reinforced shaft to enhance pushability and maintain lumen patency
• Radiopaque distal marker for clear visualization and positioning
• 1.7Fr tip (Veloute™) and 1.9Fr tip (Tellus™) for improved distal access
• Flexible distal segment with straight and angled shapes for access in small, tortuous vessels
• Hydrophilic coating for smooth tracking and transitions

Verified performance and biocompatibility

Comprehensive bench testing demonstrated conformance to acceptance criteria for tensile strength, kink resistance, flow rate, burst pressure, slidability, torque strength, and more. Tellus™ and Veloute™ biocompatibility testing per ISO 10993 confirmed non-cytotoxic, non-sensitizing, non-pyrogenic, non-hemolytic, and thromboresistant performance.

"With Veloute and Tellus, we set out to give interventional radiologists the confidence to reach and treat," said Joe Wright, General Manager, ASAHI INTECC USA. "This launch brings our catheter engineering heritage to peripheral embolization — pairing trackability and stability with the tactile control physicians expect from ASAHI."

Availability & call to action

U.S. availability begins September 8, 2025. For more information about the Veloute and Tellus products or to schedule a product demonstration, please visit https://asahi-inteccusa-medical.com/ or contact your Asahi Intecc USA representative.

About ASAHI INTECC

ASAHI INTECC Co., Ltd. manufactures medical devices, industrial materials, and innovative products with unique and unprecedented wire processing technology. ASAHI INTECC's operations are spread across the US, Europe, Singapore, China, and Hong Kong and are headquartered in Seto, Japan.

ASAHI INTECC USA, Inc. is located in Irvine, California. For more information on ASAHI INTECC's Medical products handled by ASAHI INTECC USA, Inc., please visit us at https://asahi-inteccusa-medical.com/

View original content to download multimedia:https://www.prnewswire.com/news-releases/asahi-intecc-launches-veloute-and-tellus-embolization-microcatheters-in-the-us-302548006.html

SOURCE Asahi Intecc USA Inc.